Leukocyte inclusion bodies, Menorrhagia, Myocardial infarction, Nephritis, Nephropathy, Neutrophil inclusion bodies, Presenile cataracts, Prolonged bleeding time, Proteinuria, Renal insufficiency, Sensorineural hearing impairment, Spontaneous, recurrent epistaxis, Thrombocytopenia

abnormal lymph node cell ratio, abnormal megakaryocyte differentiation, abnormal megakaryocyte morphology, abnormal placenta fetal blood space morphology, abnormal placenta intervillous maternal lacunae morphology, abnormal placenta labyrinth morphology, abnormal placenta morphology, abnormal placental labyrinth vasculature morphology, abnormal podocyte morphology, abnormal spongiotrophoblast layer morphology, abnormal thrombopoiesis, abnormal vascular branching morphogenesis, abnormal visceral endoderm morphology, abnormal vitelline vasculature morphology, cardiovascular system phenotype, decreased embryo size, embryo phenotype, embryonic growth retardation, embryonic lethality between implantation and somite formation, complete penetrance, embryonic lethality during organogenesis, complete penetrance, failure to gastrulate, fused podocyte foot processes, growth/size/body region phenotype, hearing/vestibular/ear phenotype, hematopoietic system phenotype, homeostasis/metabolism phenotype, increased incidence of corneal inflammation, increased or absent threshold for auditory brainstem response, increased renal glomerulus basement membrane thickness, increased sensitivity to induced morbidity/mortality, increased susceptibility to age-related hearing loss, increased susceptibility to injury, no abnormal phenotype detected, pale yolk sac, podocyte foot process effacement, podocyte microvillus transformation, prenatal lethality, complete penetrance, preweaning lethality, complete penetrance, renal cast, renal/urinary system phenotype, thin placenta labyrinth, vision/eye phenotype